Physician profile
Kate E Bounds
NPI 1619515137
$610.22
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $198 · 2022: $14.63 · 2023: $235 · 2024: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $397.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $189.06 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $128.40 | 2023-2024 | Dupixent, Libtayo |
| Sun Pharmaceutical Industries INC. | $86.81 | 2023-2024 | Blu-U, Odomzo, Ilumya |
| Biofrontera INC. | $51.97 | 2023-2024 | Xepi, Bf-Rhodoled, Ameluz |
| Janssen Biotech, INC. | $41.09 | 2023-2024 | Tremfya, Stelara, Simponi Aria |
| E.R. Squibb & Sons, L.L.C. | $39.01 | 2023-2024 | Sotyktu |
| Lilly USA, LLC | $28.77 | 2023-2024 | Olumiant, Taltz |
| Galderma Laboratories, L.P. | $23.47 | 2021 | |
| Ucb, INC. | $21.64 | 2024 | Bimzelx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kate Bounds listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.